Cargando…

Crataegus Extract WS®1442 Stimulates Cardiomyogenesis and Angiogenesis From Stem Cells: A Possible New Pharmacology for Hawthorn?

Extracts from the leaves and flowers of Crataegus spp. (i.e., hawthorn species) have been traditionally used with documented preclinical and clinical activities in cardiovascular medicine. Based on reported positive effects on heart muscle after ischemic injury and the overall cardioprotective profi...

Descripción completa

Detalles Bibliográficos
Autores principales: Halver, Jonas, Wenzel, Kristin, Sendker, Jandirk, Carrillo García, Carmen, Erdelmeier, Clemens A. J., Willems, Erik, Mercola, Mark, Symma, Nico, Könemann, Stephanie, Koch, Egon, Hensel, Andreas, Schade, Dennis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902660/
https://www.ncbi.nlm.nih.gov/pubmed/31849643
http://dx.doi.org/10.3389/fphar.2019.01357
_version_ 1783477717399764992
author Halver, Jonas
Wenzel, Kristin
Sendker, Jandirk
Carrillo García, Carmen
Erdelmeier, Clemens A. J.
Willems, Erik
Mercola, Mark
Symma, Nico
Könemann, Stephanie
Koch, Egon
Hensel, Andreas
Schade, Dennis
author_facet Halver, Jonas
Wenzel, Kristin
Sendker, Jandirk
Carrillo García, Carmen
Erdelmeier, Clemens A. J.
Willems, Erik
Mercola, Mark
Symma, Nico
Könemann, Stephanie
Koch, Egon
Hensel, Andreas
Schade, Dennis
author_sort Halver, Jonas
collection PubMed
description Extracts from the leaves and flowers of Crataegus spp. (i.e., hawthorn species) have been traditionally used with documented preclinical and clinical activities in cardiovascular medicine. Based on reported positive effects on heart muscle after ischemic injury and the overall cardioprotective profile, the present study addressed potential contributions of Crataegus extracts to cardiopoietic differentiation from stem cells. The quantified Crataegus extract WS(®)1442 stimulated cardiomyogenesis from murine and human embryonic stem cells (ESCs). Mechanistically, this effect was found to be induced by promoting differentiation of cardiovascular progenitor cell populations but not by proliferation. Bioassay-guided fractionation, phytochemical and analytical profiling suggested high-molecular weight ingredients as the active principle with at least part of the activity due to oligomeric procyanidines (OPCs) with a degree of polymerization between 3 and 6 (DP3–6). Transcriptome profiling in mESCs suggested two main, plausible mechanisms: These were early, stress-associated cellular events along with the modulation of distinct developmental pathways, including the upregulation of brain-derived neurotrophic factor (BDNF) and retinoic acid as well as the inhibition of transforming growth factor β/bone morphogenetic protein (TGFβ/BMP) and fibroblast growth factor (FGF) signaling. In addition, WS(®)1442 stimulated angiogenesis ex vivo in Sca-1(+) progenitor cells from adult mice hearts. These in vitro data provide evidence for a differentiation promoting activity of WS(®)1442 on distinct cardiovascular stem/progenitor cells that could be valuable for therapeutic heart regeneration after myocardial infarction. However, the in vivo relevance of this new pharmacological activity of Crataegus spp. remains to be investigated and active ingredients from bioactive fractions will have to be further characterized.
format Online
Article
Text
id pubmed-6902660
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-69026602019-12-17 Crataegus Extract WS®1442 Stimulates Cardiomyogenesis and Angiogenesis From Stem Cells: A Possible New Pharmacology for Hawthorn? Halver, Jonas Wenzel, Kristin Sendker, Jandirk Carrillo García, Carmen Erdelmeier, Clemens A. J. Willems, Erik Mercola, Mark Symma, Nico Könemann, Stephanie Koch, Egon Hensel, Andreas Schade, Dennis Front Pharmacol Pharmacology Extracts from the leaves and flowers of Crataegus spp. (i.e., hawthorn species) have been traditionally used with documented preclinical and clinical activities in cardiovascular medicine. Based on reported positive effects on heart muscle after ischemic injury and the overall cardioprotective profile, the present study addressed potential contributions of Crataegus extracts to cardiopoietic differentiation from stem cells. The quantified Crataegus extract WS(®)1442 stimulated cardiomyogenesis from murine and human embryonic stem cells (ESCs). Mechanistically, this effect was found to be induced by promoting differentiation of cardiovascular progenitor cell populations but not by proliferation. Bioassay-guided fractionation, phytochemical and analytical profiling suggested high-molecular weight ingredients as the active principle with at least part of the activity due to oligomeric procyanidines (OPCs) with a degree of polymerization between 3 and 6 (DP3–6). Transcriptome profiling in mESCs suggested two main, plausible mechanisms: These were early, stress-associated cellular events along with the modulation of distinct developmental pathways, including the upregulation of brain-derived neurotrophic factor (BDNF) and retinoic acid as well as the inhibition of transforming growth factor β/bone morphogenetic protein (TGFβ/BMP) and fibroblast growth factor (FGF) signaling. In addition, WS(®)1442 stimulated angiogenesis ex vivo in Sca-1(+) progenitor cells from adult mice hearts. These in vitro data provide evidence for a differentiation promoting activity of WS(®)1442 on distinct cardiovascular stem/progenitor cells that could be valuable for therapeutic heart regeneration after myocardial infarction. However, the in vivo relevance of this new pharmacological activity of Crataegus spp. remains to be investigated and active ingredients from bioactive fractions will have to be further characterized. Frontiers Media S.A. 2019-11-27 /pmc/articles/PMC6902660/ /pubmed/31849643 http://dx.doi.org/10.3389/fphar.2019.01357 Text en Copyright © 2019 Halver, Wenzel, Sendker, Carrillo García, Erdelmeier, Willems, Mercola, Symma, Könemann, Koch, Hensel and Schade http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Halver, Jonas
Wenzel, Kristin
Sendker, Jandirk
Carrillo García, Carmen
Erdelmeier, Clemens A. J.
Willems, Erik
Mercola, Mark
Symma, Nico
Könemann, Stephanie
Koch, Egon
Hensel, Andreas
Schade, Dennis
Crataegus Extract WS®1442 Stimulates Cardiomyogenesis and Angiogenesis From Stem Cells: A Possible New Pharmacology for Hawthorn?
title Crataegus Extract WS®1442 Stimulates Cardiomyogenesis and Angiogenesis From Stem Cells: A Possible New Pharmacology for Hawthorn?
title_full Crataegus Extract WS®1442 Stimulates Cardiomyogenesis and Angiogenesis From Stem Cells: A Possible New Pharmacology for Hawthorn?
title_fullStr Crataegus Extract WS®1442 Stimulates Cardiomyogenesis and Angiogenesis From Stem Cells: A Possible New Pharmacology for Hawthorn?
title_full_unstemmed Crataegus Extract WS®1442 Stimulates Cardiomyogenesis and Angiogenesis From Stem Cells: A Possible New Pharmacology for Hawthorn?
title_short Crataegus Extract WS®1442 Stimulates Cardiomyogenesis and Angiogenesis From Stem Cells: A Possible New Pharmacology for Hawthorn?
title_sort crataegus extract ws®1442 stimulates cardiomyogenesis and angiogenesis from stem cells: a possible new pharmacology for hawthorn?
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902660/
https://www.ncbi.nlm.nih.gov/pubmed/31849643
http://dx.doi.org/10.3389/fphar.2019.01357
work_keys_str_mv AT halverjonas crataegusextractws1442stimulatescardiomyogenesisandangiogenesisfromstemcellsapossiblenewpharmacologyforhawthorn
AT wenzelkristin crataegusextractws1442stimulatescardiomyogenesisandangiogenesisfromstemcellsapossiblenewpharmacologyforhawthorn
AT sendkerjandirk crataegusextractws1442stimulatescardiomyogenesisandangiogenesisfromstemcellsapossiblenewpharmacologyforhawthorn
AT carrillogarciacarmen crataegusextractws1442stimulatescardiomyogenesisandangiogenesisfromstemcellsapossiblenewpharmacologyforhawthorn
AT erdelmeierclemensaj crataegusextractws1442stimulatescardiomyogenesisandangiogenesisfromstemcellsapossiblenewpharmacologyforhawthorn
AT willemserik crataegusextractws1442stimulatescardiomyogenesisandangiogenesisfromstemcellsapossiblenewpharmacologyforhawthorn
AT mercolamark crataegusextractws1442stimulatescardiomyogenesisandangiogenesisfromstemcellsapossiblenewpharmacologyforhawthorn
AT symmanico crataegusextractws1442stimulatescardiomyogenesisandangiogenesisfromstemcellsapossiblenewpharmacologyforhawthorn
AT konemannstephanie crataegusextractws1442stimulatescardiomyogenesisandangiogenesisfromstemcellsapossiblenewpharmacologyforhawthorn
AT kochegon crataegusextractws1442stimulatescardiomyogenesisandangiogenesisfromstemcellsapossiblenewpharmacologyforhawthorn
AT henselandreas crataegusextractws1442stimulatescardiomyogenesisandangiogenesisfromstemcellsapossiblenewpharmacologyforhawthorn
AT schadedennis crataegusextractws1442stimulatescardiomyogenesisandangiogenesisfromstemcellsapossiblenewpharmacologyforhawthorn